Johnson &amp; Johnson to Buy Guidant for $25.4B
5729
Health care products giant Johnson &amp; Johnson&#39;s $25.4 billion acquisition of Guidant Corp. could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
351599
NEW YORK -- Johnson &amp; Johnson will acquire Guidant Corp., one of the world&#39;s leading makers of cardiac devices, for about $25.4 billion in cash and stock.
739833
U.S. blue chips rose  on Thursday,  boosted by Johnson & Johnson JNJ.N following its move to buy  Guidant Corp. GDT.N, but market gains were limited after  Goldman Sachs posted disappointing revenues.
667986
U.S. stocks were little changed on  Tuesday, with oil prices dropping below $42 a barrel helping to  support markets, but Johnson & Johnson JNJ.N put pressure on  the Dow following a report of a possible $24 billion takeover  of cardiovascular device maker Guidant Corp. GDT.N.
646222
The anticipated merger of Guidant Corp. and Johnson &amp; Johnson could give an unintended boost to Boston Scientific Corp. if Guidant's drug-coated stent launch is delayed, said analysts looking at the implications of a potential deal.
336179
LONDON: Johnson &amp; Johnson has agreed to acquire Guidant Corp for US$25.4bil, adding electrical devices for treating heart disease to a line-up of thousands of health products ranging from Band-Aids to cardiac stents.
661105
US health titan Johnson and Johnson has reached a deal to acquire US heart device manufacturer Guidant Corporation, in a stock-and-cash deal valued at $23.9 billion, based on $76 a share, the companies said in a statement early this morning.
546307
Johnson &amp; Johnson (nyse: JNJ - news - people ) is said to be in advanced talks to buy medical device maker Guidant (nyse: GDT - news - people ) for more than $24 billion.
560518
New York (dpa) - Health-care conglomerate Johnson &amp; Johnson is in advanced negotiations to buy defibrillator maker Guidant Corp.
72369
Johnson &amp; Johnson (J&amp;J) agreed yesterday to acquire Guidant Corporation for $25.4 billion (R147 billion), adding electrical devices for treating heart disease to
368114
Johnson &amp; Johnson announced last night that will buy medical-device maker Guidant for $23.9 billion in cash and stock. The deal, approved by both boards but subject to regulator approval, is one of the largest
199086
Johnson & Johnson has agreed to  buy Guidant Corp. for $25.4 billion in cash and stock, the  companies said on Wednesday, giving the healthcare products  maker a foothold in the fast-growing market for implantable  devices that regulate heartbeats.
329296
Stocks stalled at the open Tuesday as investors shrugged off the impact of weaker crude prices and reports that Johnson &amp; Johnson is seeking to buy Guidant in a $24 billion deal.
160352
Health care and consumer products maker Johnson & Johnson is in negotiations to acquire medical-device maker Guidant Corp., sources familiar with the situation said on Tuesday.
177578
Even as the ink dries on Johnson &amp; Johnson&#39;s agreement to buy Guidant Corp. for $25.4 billion, it remains on the hunt for other companies that could bolster
731068
Johnson & Johnson will acquire the cardiac device manufacturer for $25.4 billion. The acquisition is the largest business deal in J&J's 118-year history
570795
Health care and consumer products maker Johnson & Johnson  on Sunday was close to finalizing details of a &#36;24 billion cash and stock acquisition of medical-device maker Guidant Corp. , according to people familiar with the matter.